Facile synthesis, antibacterial activity and molecular properties prediction of some new 1, 3-dihydroimidazol-2-thione derivatives

Letters in Drug Design and Discovery

Volumn 8, Issue 9, 2011, Pages 763-768

  Junejo, Julfikar Ali ^a   Ghosh, Surajit Kumar ^a   Shaikh, Mutahar ^a   Gahtori, Prashant ^a   Singh, Udaya Pratap ^b  

^a DIBRUGARH UNIVERSITY   (India)

^b SAM HIGGINBOTTOM UNIVERSITY OF AGRICULTURE   (India)

Author keywords

1 benzoyl 3 (substituted phenyl) thiourea; Broth dilution method; Disk diffusion; Molecular property

Indexed keywords

1 BENZOYL 3 (3' CHLORO 4' FLUOROPHENYL) 4 METHYL 1,3 DIHYDROIMIDAZOL 2 THIONE; 1 BENZOYL 3 (3' NITROPHENYL) 4 METHYL 1,3 DIHYDROIMIDAZOL 2 THIONE; 1 BENZOYL 3 (4' FLUOROPHENYL) 4 METHYL 1,3 DIHYDROIMIDAZOL 2 THIONE; 1 BENZOYL 3 (4' METHOXYPHENYL) 4 METHYL 1,3 DIHYDROIMIDAZOL 2 THIONE; 1 BENZOYL 3 (4' METHYLPHENYL) 4 METHYL 1,3 DIHYDROIMIDAZOL 2 THIONE; 1 BENZOYL 3 (4' NITROPHENYL) 4 METHYL 1,3 DIHYDROIMIDAZOL 2 THIONE; 1,3 DIHYDROIMIDAZOL 2 THIONE DERIVATIVE; ANTIINFECTIVE AGENT; BROMINE; OFLOXACIN; THIOUREA DERIVATIVE; TRIETHYLAMINE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; SPECTROSCOPY;

EID: 80053039239     PISSN: 15701808     EISSN: 1875628X     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Spellberg, B.; Powers, J. H.; Brass, E. P.; Miller, L. G.; Edwards, J. E. Jr. Trends in antimicrobial drug development: implications for the future. Clin. Infect. Dis., 2004, 38(9), 1279-1286. (Pubitemid 38608571)
2. st century. Curr. Opin. Microbiol., 2001, 4(6), 491-492. (Pubitemid 32964094)
3. Payne, D.; Tomasz, A. Antimicrobials: The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents. Curr. Opin. Microbiol., 2004, 7(5), 435-438. (Pubitemid 39297121)
4. Schrag, S. J.; Perrot, V.; Levin, B. R. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proc. R. Soc. Lond. B Biol. Sci., 1997, 264(1386), 1287-1291. (Pubitemid 27445226)
5. White, D. G.; Zhao, S.; Sudler, R.; Ayers, S.; Friedman, S.; Chen, S.; McDermott, P. F.; McDermott, S.; Wagner, D. D.; Meng, J. The isolation of antibiotic-resistant salmonella from retail ground meats. N. Engl. J. Med., 2001, 345(16), 1147-1154.
6. Waldvogel, F. A. New resistance in Staphylococcus aureus. N. Engl. J. Med., 1999, 340(7), 556-557. (Pubitemid 29093292)
7. Carmeli, Y.; Troillet, N.; Eliopoulos, G. M.; Samore, M. H. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob. Agents Chemother., 1999, 43(6), 1379-1382. (Pubitemid 29259329)
8. Sorensen, T. L.; Blom, M.; Monnet, D. L.; Frimodt-Moller, N.; Poulsen, R. L.; Espersen, F. Transient intestinal carriage after ingestion of antibiotic-resistant Enterococcus faecium from chicken and pork. N Engl. J. Med., 2001, 345(16), 1161-1166.
9. Amsden, G. W. Pneumococcal resistance in perspective: how well are we combating it? Pediatr. Infect. Dis. J., 2004, 23(2 Suppl), S125-S128. (Pubitemid 38222807)
10. Alanis, A. J. Resistance to Antibiotics: Are We in the Post-Antibiotic Era? Arch. Med. Res., 2005, 36(6), 697-705. (Pubitemid 41436239)
11. Aragoni, M. C.; Arca, M.; Demartin, F.; Devillanova, F. A.; Garau, A.; Isaia, F.; Lippolis, V.; Verani, G. Anti-thyroid drug methimazole: X-ray characterization of two novel ionic disulfides obtained from its chemical oxidation by I (2). J. Am. Chem. Soc., 2000, 124(17), 45388-45389.
12. Kruse, L. I.; Kaiser, C.; DeWolf, W. E.; Walter, E.; Finkelstein, J. A.; Frazee, J. S.; James, S.; Hilbert, E. L.; Ross, S. T.; Stephen, T.; Flaim, K. E.; Sawyer, J. L. J. Med. Chem., 1990, 33(2), 781-789.
13. Lagoja, I. M.; Pannecouque, C.; Aerschot, A. V.; Myriam, W.; Debyser, Z.; Balzarini, J.; Herdewijin, P.; Clercq, E. D. N-aminoimidazole derivatives inhibiting retroviral replication via a yet unidentified mode of action. J. Med. Chem., 2003, 46(8), 1546-1553. (Pubitemid 36512718)
14. Smith, R. C.; Gore, J. Z. 2-Imidazolethiones protect ascorbic acid from oxidation induced by copper. Biochim. Biophys. Acta., 1990, 1034(3), 263-267. (Pubitemid 20183632)
15. Saeed, A.; Batool, M. Synthesis and bioactivity of some new 1-tolyl-3-aryl-4-methylimidazole-2-thiones. Med. Chem. Res., 2007, 16(3), 143-154. (Pubitemid 351214249)
16. Singh, U. P.; Singh, R. K.; Bhat, H. R.; Subhaschandra, Y. P.; Kumar, V.; Kumawat, M. K.; Gahtori P. Synthesis and antibacterial evaluation of series of novel tri-substituted-s-triazine derivatives. Med. Chem. Res. 2010, In Press, DOI: 10.1007/s00044-010-9446-7.
17. Gahtori, P.; Das, A.; Bhatt, H. Synthesis and Antibacterial Assessment of N-[4-(4-substituted phenyl)-1, 3-thiazol-2-yl]-1, 3, 5-triazin-2-amine. Indian J. Pharm. Sci., 2009, 71(1), 79-82.
18. www.molinspiration. com
19. Ertl, P.; Rohde, B.; Selzer, P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J. Med. Chem., 2000, 43(20), 3714-3717.
20. Veber, D. F.; Johnson, S. R.; Cheng, H. Y.; Smith, B. R.; Ward, K. W.; Kopple, K. D. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem., 2002, 45(12), 2615-2623. (Pubitemid 34595232)
21. Lipinski, C. A.; Lombardo F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug. Delivery Rev., 1997, 23(1-3), 4-25.
22. Özer, C. K.; Arslan, H.; Van Derveer, D.; Külcü, N. Synthesis and characterization of N-(Arylcarbamothioyl)-cyclohexanecarboxamide derivatives: the crystal structure of N-(naphthalen-1-ylcarbamothioyl) cyclohexanecarboxamide. Molecules, 2009, 14(2), 655-666.
23. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution, Clin. Microbiol. Infect., 2000, 6(9), 509-515.
24. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard-Ninth Edition. Clinical and Laboratory Standards, Institute document M2-A9 [ISBN 1-56238-586-0]. 2006. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, 19087-1898, USA.